The Middle East Health Journal
SEE OTHER BRANDS

Catch up with healthcare and wellness news from the Middle East

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on April 29, 2025

Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services

Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services

MCLEAN, Va., April 29, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today …

Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting

Fate Therapeutics Announces Five Presentations on Off-the-Shelf CAR T-cell Product Platform at ASGCT Annual Meeting

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to …

FibroBiologics Presenting at the ThymUS 2025 Meeting

FibroBiologics Presenting at the ThymUS 2025 Meeting

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic …

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting

Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting

Combination treatment of TFF2 with anti-PD1 antibody was associated with the activation of cancer-killing CD8+ T Cells and limiting immune evasion by tumor cells TNX-1700 is in preclinical development for gastric and colorectal cancers CHATHAM, N.J., April …

WeightWatchers Streamlines Member Access to Zepbound® Vials with LillyDirect® Pharmacy Provider

WeightWatchers Streamlines Member Access to Zepbound® Vials with LillyDirect® Pharmacy Provider

NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”), the global leader in science-backed weight management, today announced a pharmacy integration with Eli Lilly and Company’s LillyDirect® …

Best Probiotics For Weight Loss: Top Rated Probiotic Supplements For Belly Fat & Menopause Women Over 50 – WOLFSON BRANDS (UK) LIMITED

Best Probiotics For Weight Loss: Top Rated Probiotic Supplements For Belly Fat & Menopause Women Over 50 – WOLFSON BRANDS (UK) LIMITED

Glasgow, April 29, 2025 (GLOBE NEWSWIRE) -- Whenever there is a reference to health or well-being, probiotics will be commonly mentioned. Multiple natural probiotics exist, all claiming to heal all ailments. Probiotics are currently trendy and aid in …

Best Legal Steroids for Muscle Growth, Fat Loss, and Strength: Top Natural Alternatives to Anabolic Steroids For Sale (By CrazyBulk)

Best Legal Steroids for Muscle Growth, Fat Loss, and Strength: Top Natural Alternatives to Anabolic Steroids For Sale (By CrazyBulk)

New York City, April 29, 2025 (GLOBE NEWSWIRE) -- If you’re serious about building muscle mass, shredding fat, and unlocking peak physical performance — without risking your health — then legal steroid alternatives could be your ultimate game-changer. …

Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025

Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025

SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first quarter 2025 earnings conference call at 4:30 pm EDT on Tuesday, May 6, 2025. The …

Muscular Dystrophy Association Launches National ALS Awareness Campaign to Accelerate the Search for a Cure

Muscular Dystrophy Association Launches National ALS Awareness Campaign to Accelerate the Search for a Cure

New York, April 29, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced the launch of its nationwide campaign focused on amyotrophic lateral sclerosis (ALS) during ALS Awareness Month in May, honoring a powerful legacy that …

USA Today Names HealthEquity to its Top 25 Workplaces

USA Today Names HealthEquity to its Top 25 Workplaces

DRAPER, Utah, April 29, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation’s largest health savings account (HSA) administrator, today announced it has been named a USA Today Top Workplace for 2025, ranking 23rd …

Four-year Follow-up Data on SPRINT® PNS for Low Back Pain Highlights Sustained Pain Relief Avoiding Costly and Invasive Treatments

Four-year Follow-up Data on SPRINT® PNS for Low Back Pain Highlights Sustained Pain Relief Avoiding Costly and Invasive Treatments

CLEVELAND, April 29, 2025 (GLOBE NEWSWIRE) -- SPR announced the publication of long-term follow-up survey data from a prospective, multicenter study that demonstrated significant and sustained pain relief more than four years after treatment with 60-day …

“Planting the Conversation” for Mental Health Awareness Month

“Planting the Conversation” for Mental Health Awareness Month

DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- As mental health challenges continue to rise in workplaces globally, “Gardenuity for Business,” the B2B wellness solution from Gardenuity, is scaling its efforts to help companies care for their teams. Donna …

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

Orchestra BioMed Receives FDA Approval of IDE to Initiate U.S. Coronary Pivotal Trial Randomizing First-in-Class Sirolimus-AngioInfusion Balloon, Virtue SAB, Head-to-Head with Paclitaxel-Coated Balloon

Orchestra BioMed’s Virtue® Sirolimus AngioInfusion Balloon™ (“Virtue SAB”) is the only non-coated drug-eluting balloon system under clinical investigation worldwide and has been awarded multiple FDA Breakthrough Device Designations The Virtue Trial will be …

What Does it Mean to Be APOL1 Aware? American Kidney Fund Drives Efforts to Raise Awareness About AMKD, a Serious Genetic Disease Impacting the Black Community

What Does it Mean to Be APOL1 Aware? American Kidney Fund Drives Efforts to Raise Awareness About AMKD, a Serious Genetic Disease Impacting the Black Community

ROCKVILLE, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Today the American Kidney Fund (AKF) announces the second annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day, a day to educate communities about this genetic form of rapidly progressive kidney …

The International Myeloma Foundation Mourns the Loss of Board Member and Longtime Philanthropist John O’Dwyer

The International Myeloma Foundation Mourns the Loss of Board Member and Longtime Philanthropist John O’Dwyer

STUDIO CITY, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announced with great sadness, the passing of one of the IMF’s Board Members and longtime philanthropist John O’Dwyer, who lived with myeloma for 18 …

Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025

Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025

SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today outlined a framework for a pioneering …

Digital Utilities Ventures Announces Planned Name Change and Corporate Move as Strategic Evolution Continues

Digital Utilities Ventures Announces Planned Name Change and Corporate Move as Strategic Evolution Continues

Digital Utilities Ventures (OTC: DUTV) is evolving into Easy Environmental Solutions, Inc., to better reflect its focus on environmental sustainability. The company will continue to advance regenerative agriculture, clean water access, and a net carbon- …

Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer

Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer

Data presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 Annamycin is potentially a highly versatile drug capable of working synergistically with numerous mechanistically different FDA approved anticancer first line …

Voom Medical Devices, Inc. Announces $30 Million Debt and Equity Financing

Voom Medical Devices, Inc. Announces $30 Million Debt and Equity Financing

BRENTWOOD, Tenn., April 29, 2025 (GLOBE NEWSWIRE) -- Voom Medical Devices, Inc. (“Voom” or “the Company”), a leader in minimally invasive orthopedic solutions, today announced the successful closing of a $30 million capital raise through a combination of …

Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025

Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025

SOUTH SAN FRANCISCO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service